100 Years after Alzheimer: Contemporary neurology practice assessment of referrals for dementia

American Journal of Alzheimer's Disease and other Dementias

Volumn 23, Issue 6, 2009, Pages 516-527

  Chow, Tiffany W ^a,b,c   Binder, Carin ^d   Smyth, Steven ^d   Cohen, Sharon ^a,e   Robillard, Alain ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ROTMAN RESEARCH INSTITUTE   (Canada)

^d Janssen Ortho Inc   (Canada)

^e Toronto Memory Program   (Canada)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Dementia; Physician's practice patterns; Referral and consultation; Specialist

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; DONEPEZIL; GALANTAMINE; MEMANTINE; NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DISEASE SEVERITY; GENERAL PRACTITIONER; HUMAN; MEDICAL PRACTICE; MENTAL DISEASE; NEUROLOGIC DISEASE; PATIENT ASSESSMENT; PATIENT REFERRAL; PRIMARY MEDICAL CARE; STRUCTURED QUESTIONNAIRE;

EID: 58149204440     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317508328194     Document Type: Article

References (16)

1. Lindsay J., Sykes E., McDowell I., et al. More than the epidemiology of Alzheimer's disease: contributions of the Canadian Study of Health and Aging. Can J Psychiatr. 2004 ; 49: 83-91.
2. Herbert Liesi E., Scherr Paul A., Bienias Julia L., Bennett David A., Evans Denis A. Alzheimer disease in the US population. Prevalence estimates using the 2000 Census. Arch Neurol. 2003 ; 60: 1119-1122.
3. Ostbye T., Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J. 1994 ; 151: 2457-1464.
4. Schubert CC, Boustani M., Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker ? J Am Geriatr Soc. 2006 ; 54: 104-109.
5. Gill SS, Mamdani M., Naglie G., et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med. 2005 ; 165: 808-813.
6. Bergman-Evans B. Evidence-based guideline. Improving medication management for older adult clients. J Gerontol Nurs. 2006 ; 32: 6-14.
7. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 ; 56: 1143-1153.
8. Petersen RC, Stevens JC, Ganguli M., Tangalos EG, Cummings JL, DeKosky ST Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 ; 56: 1133-1142.
9. Cody M., Beck C., Shue VM, Pope S. Reported practices of PCPs in the diagnosis and management of dementia. Aging Ment Health. 2002 ; 1: 72-76.
10. Gauthier S., Feldman H., Keran R., et al. Sooner versus later: which dementia symptoms and co-morbid conditions initiate physician contact? Presented as a poster at the International Society of Vascular, Behavioral and Cognitive Disorders. San Antonio, Texas, July 11-15, 2007.
11. Forette F., Seux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 ; 352: 1347-1351.
12. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001 ; 358: 1033-1041.
13. Rockwood K., MacKnight C., Wentzel C., et al. for the CIVIC Investigators. The diagnosis of ''Mixed'' dementia in the consortium for the investigation of vascular impairment of cognition (CIVIC). Ann N Y Acad Sci. 2000 ; 903: 522-528.
14. Shepherd J., Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet. 2002 ; 360: 1623-1630.
15. Hansson L., Lithel H., Skoog I., et al. Study on Cognition and Prognosis in the Elderly (SCOPE): baseline characteristics. Blood Press. 2000 ; 9: 146-151.
16. Waldemar G., Dubois B., Emre M., et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007 ; 14: e1 - e26.